Pathogenetic Basis of Aortopathy and Aortic Valve Disease
B
Benjamin Landis, MD
Primary Investigator
Recruiting
100 years and younger
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to identify genes related to aortopathy and aortic valve disease in order to determine the risk and severity of aortic disease in individuals starting at an early age or stage of disease.
Detailed description of study
The purpose of this study is to obtain information from individuals and their families in order to define the complex genetic and pathogenic basis of thoracic aortic aneurysm and other forms of aortopathy and aortic valve disease by identifying new disease-causing genes and by identifying important genetic modifiers for aortic/aortic valve disease severity.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: aortopathy,aortic valve disease, Riley
-
Age: - 100 Years
-
Gender: All
Inclusion Criteria
Subjects with aortic disease including TAA* or dissection, aortic tortuosity, or aortic hypoplasia/stenosis (based on any cardiac imaging modality including echocardiography, CT, MRI, or angiography)
Subjects with a syndromic or genetic diagnosis that poses risk for the development of aortic disease who have not yet developed disease
Subjects with aortic valve disease
Family members of eligible subjects
Control subjects having tissue removed during a surgical procedure
Tissue donors who have authorized the use of their specimens for research
Leftover specimens being stored within an Indiana University and/or Indiana University Health lab or storage facility from patients who fall into previously described inclusion criteria
Exclusion Criteria
Inability or unwillingness to provide consent
Additional Information:Subjects with aortic disease including TAA* or dissection, aortic tortuosity, or aortic hypoplasia/stenosis (based on any cardiac imaging modality including echocardiography, CT, MRI, or angiography)
Subjects with a syndromic or genetic diagnosis that poses risk for the development of aortic disease who have not yet developed disease
Subjects with aortic valve disease
Family members of eligible subjects
Control subjects having tissue removed during a surgical procedure
Tissue donors who have authorized the use of their specimens for research
Leftover specimens being stored within an Indiana University and/or Indiana University Health lab or storage facility from patients who fall into previously described inclusion criteria
Exclusion Criteria
Inability or unwillingness to provide consent
Participants may be compensated for their participation.
Updated on
13 Sep 2024.
Study ID: 1509977311
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
